Investments
69Portfolio Exits
17Funds
4
Want to inform investors similar to Vestcorp AG about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Vestcorp AG Investments
69 Investments
Vestcorp AG has made 69 investments. Their latest investment was in CoImmune as part of their Debt - II on September 9, 2010.
Vestcorp AG Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/13/2010 | Debt - II | CoImmune | $4.85M | Yes | AAC Capital Partners, Aurora Funds, BD Ventures, CDP Capital, Cordova Ventures, Forbion Capital Partners, GeneChem Therapeutics Venture Fund, Harbinger/Aurora Venture Fund, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Ventures, Mizuho Capital, Morningside Ventures, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, Signet Healthcare Partners, Sutter Hill Ventures, TFG Capital Unternehmensbeteiligungsgesellschaft, TVM Capital Life Science, and Vestcorp AG | |
5/27/2003 | Secondary Market | Xionet | No | Undisclosed Angel Investors, and Vestcorp AG | 1 | |
5/1/2003 | Convertible Note - II | NiceTec | $0.15M | No | Undisclosed Investors, and Vestcorp AG | 1 |
12/15/2002 | Growth Equity - II | |||||
6/1/2002 | Series B |
Date | 9/13/2010 | 5/27/2003 | 5/1/2003 | 12/15/2002 | 6/1/2002 |
|---|---|---|---|---|---|
Round | Debt - II | Secondary Market | Convertible Note - II | Growth Equity - II | Series B |
Company | CoImmune | Xionet | NiceTec | ||
Amount | $4.85M | $0.15M | |||
New? | Yes | No | No | ||
Co-Investors | AAC Capital Partners, Aurora Funds, BD Ventures, CDP Capital, Cordova Ventures, Forbion Capital Partners, GeneChem Therapeutics Venture Fund, Harbinger/Aurora Venture Fund, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Ventures, Mizuho Capital, Morningside Ventures, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, Signet Healthcare Partners, Sutter Hill Ventures, TFG Capital Unternehmensbeteiligungsgesellschaft, TVM Capital Life Science, and Vestcorp AG | Undisclosed Angel Investors, and Vestcorp AG | Undisclosed Investors, and Vestcorp AG | ||
Sources | 1 | 1 |
Vestcorp AG Portfolio Exits
17 Portfolio Exits
Vestcorp AG has 17 portfolio exits. Their latest portfolio exit was Inmatec on February 22, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/22/2021 | Acquired | 1 | |||
2/7/2014 | IPO | Public | 3 | ||
2/8/2013 | Acquired | Undisclosed Investors | |||
Vestcorp AG Fund History
4 Fund Histories
Vestcorp AG has 4 funds, including Technologie-Fonds II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
Technologie-Fonds II | Early-Stage Venture Capital | Closed | 1 | ||
Technologie-Fonds III | |||||
BLS Venture Fonds | |||||
Technologie-Fonds I |
Closing Date | ||||
|---|---|---|---|---|
Fund | Technologie-Fonds II | Technologie-Fonds III | BLS Venture Fonds | Technologie-Fonds I |
Fund Type | Early-Stage Venture Capital | |||
Status | Closed | |||
Amount | ||||
Sources | 1 |
Vestcorp AG Team
7 Team Members
Vestcorp AG has 7 team members, including current Chief Executive Officer, Udo Treichel.
Name | Work History | Title | Status |
|---|---|---|---|
Udo Treichel | Chief Executive Officer | Current | |
Name | Udo Treichel | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.